U-turn on Mounjaro price hike: drug giant scales back planned rise after backlash - new costs revealed in full

Eli Lilly, the pharmaceutical company behind the drug, has backed down to mounting pressure over the planned price hike.

U-turn on Mounjaro price hike: drug giant scales back planned rise after backlash - new costs revealed in full
Eli Lilly, the pharmaceutical company behind the drug, has backed down to mounting pressure over the planned price hike.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow